National Institute for Health and Clinical Excellence (NICE)
Printable version

NICE draft guidance provides Cancer Drugs Fund first in Europe access to new treatment option for advanced breast cancer

NICE yesterday (20 April 2021) published draft guidance recommending trastuzumab deruxtecan for use in the Cancer Drugs Fund (CDF) for treating a type of breast cancer called HER2 positive breast cancer which can’t be surgically removed or which has spread to other parts of the body.

Channel website: https://www.nice.org.uk/

Original article link: https://www.nice.org.uk/news/article/nice-draft-guidance-provides-cancer-drugs-fund-first-in-europe-access-to-new-treatment-option-for-advanced-breast-cancer

Share this article

Latest News from
National Institute for Health and Clinical Excellence (NICE)

Webinar: How local authorities can use data to better support their citizens and unlock hidden savings.